InvestorsHub Logo
Followers 22
Posts 1671
Boards Moderated 0
Alias Born 12/12/2006

Re: braden post# 119

Sunday, 05/08/2011 9:31:55 AM

Sunday, May 08, 2011 9:31:55 AM

Post# of 320
This stock has $20 written all over it. The findings from the journal adds more to the case that Difimicin will eat into Vanco's market share quickly. Treatment of C-Diff is a huge market and why would anyone prescribe vancomycin when Difimicin is so effective on cutting down the relapse rates as much as 45% ?